Porth I, Hirsch D, Ceribas Y, Weidner P, et al. Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. Eur J Cancer 2023;183:119-130.
PMID: 36848831